Jobs
-
Powder characterization specialists Freeman Technology have announced the opening of an office in Shanghai and the appointment of Joey Xie as Product Manager and Chief Representative in China. The company added that it has also… Read more . . .
-
Teva has announced that the UK High Court has invalidated AstraZeneca’s patent titled “Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma” (EP 1,085,877), which… Read more . . .
-
Cipla has announced the launch of its Serroflo salmeterol/fluticasone MDI, a generic version of Advair, in Germany and Sweden. The inhaler will be available in 25/125 mcg and 25/250 mcg versions, both of which will… Read more . . .
-
Prosonix has submitted an MAA for its PSX1001 fluticasone propionate MDI for the treatment of asthma, triggering a milestone payment from Mylan, the company has announced. In April 2014, Mylan acquired marketing rights for PSX1001… Read more . . .
-
3M Drug Delivery Systems is marking the 25th anniversary of the launch of the Aerolin Autohaler breath-activated salbutamol (albuterol) MDI. According to the company, over 120 million units of the Autohaler device have been manufactured… Read more . . .
-
Contract development company MedPharm has announced a new fast track service for topical formulation development, including for respiratory delivery. The company offers development services for a variety of OINDP formulations, including MDIs, DPIs, inhalation solutions,… Read more . . .
-
According to the FDA, the agency has issued a tentative approval of an application by PulmoFlow, Inc. to market tobramycin 300 mg/5 ml inhalation solution. PulmoFlow, Inc. was established in Virginia in 2013. The company’s… Read more . . .
-
Main purpose of the job You will take responsibility for, and participate in, the complete development cycle for Medical Product development, from preparing specifications and architecture design through to approval for volume production. The position… Read more . . .
-
Civitas Therapeutics has announced that all of its existing investors, plus seven new investors, participated in a $55 million Series C financing round. The company is developing products based on respiratory delivery technology acquired from… Read more . . .
-
The Medicon Valley Inhalation Consortium (MVIC) has announced that Ola Nerbrink has succeeded Orest Lastow as CEO. Nerbrink was previously MVIC’s VP of Business Development. Lastow, who founded MVIC in 2012, left the position in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA